ACCC logo
Facebook  LinkedIn  Twitter  ACCC Youtube Channel  ACCCBuzz blog

Association of Community Cancer Centers

The leading education and advocacy organization for the multidisciplinary cancer team

ACCCBuzz Blog  Find a Cancer Program  Log in to MyNetwork

Home > Mediaroom > Press Releases > 2012 > Association of Community Cancer Centers Publishes New Guide to Help Cancer Care Team Navigate Oncology Drugs Paid Under Medicare Part B

FOR INFORMATION CONTACT:
Lori Gardner, Senior Director
Communications & Marketing
301.984.9496 ext. 226
lgardner@accc-cancer.org

ACCC News Release

For Immediate Release: October 8, 2012

Association of Community Cancer Centers Publishes New Guide to Help Cancer Care Team Navigate Oncology Drugs Paid Under Medicare Part B

ROCKVILLE, Md.—The Association of Community Cancer Centers (ACCC) has published its Oncology Drug Reference Guide, a practical tool to help oncologists, nurses, pharmacists, financial counselors, and other oncology support and administrative staff navigate the increasingly complex area of drug information. ACCC’s Oncology Drug Reference Guide is a convenient source of information on the drugs commonly used to treat cancer.

"The Oncology Drug Reference Guide is the latest example of ACCC's many excellent educational resources and publications for the oncology community," said ACCC President George Kovach, MD. “The Oncology Drug Reference Guide also reflects ACCC’s long-standing commitment to ensuring access to quality care for all cancer patients.”

The Oncology Drug Reference Guide focuses on drugs paid under Part B of the Medicare program. It includes all such drugs that have Healthcare Common Procedure Coding System (HCPCS) codes in the oncology range (J8500 through J9600), as well as any drug newly approved by the U.S. Food and Drug Administration (FDA) for treating cancer that has yet to have been assigned a HCPCS code. The Oncology Drug Reference Guide presents each drug by HCPCS code, generic name, brand name, billing unit, and manufacturer contact information. The Oncology Drug Reference Guide lists average sales prices for all currently marketed drugs that have HCPCS billing codes in the oncology range, or that have been approved by the FDA for treating cancer. Manufacturers are identified for each brand name drug for which there is no generic equivalent. Contact information is included for both the reimbursement and medical affairs departments, for easy reference if users want to request copies of the latest evidence as well as compendia and journal reprints.

ACCC members will receive a copy of the Oncology Drug Reference Guide in the mail. Quarterly updates will be available ACCC’s website at www.accc-cancer.org/Drug Reference Guide.

About the Association of Community Cancer Centers
The Association of Community Cancer Centers (ACCC) is the leading advocacy and education organization for the multidisciplinary cancer care team. More than 23,000 cancer care professionals from over 2,000 hospitals and practices nationwide are affiliated with ACCC. It is estimated that 65 percent of the nation's cancer patients are treated by a member of ACCC. Providing a national forum for addressing issues that affect community cancer programs, ACCC is recognized as the premier provider of resources for the entire oncology care team. Our members include medical and radiation oncologists, surgeons, cancer program administrators and medical directors, senior hospital executives, practice managers, pharmacists, oncology nurses, radiation therapists, social workers, and cancer program data managers. For more information, visit ACCC's website at www.accc-cancer.org. Follow us on Facebook, Twitter, LinkedIn, and read our blog, ACCCBuzz.

Copyright © 2017 Association of Community Cancer Centers. All Rights Reserved.
1801 Research Boulevard, Suite 400, Rockville, MD 20850  |  Tel.: 301.984.9496  |  Fax: 301.770.1949

CONTACT US